Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-23

Clinical Trial Update: Proglumide and Chemotherapy for Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating proglumide in combination with chemotherapy for metastatic pancreatic cancer, with the study currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (chemotherapy)
  • Proglumide (proglumide)

Snippet

Sponsor: Georgetown University | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING